AbbVie: A 4% Yield Plus Potential Upside – What’s Not To Like?


  • We share another of the 22 Mega Cap stocks with the prospect of higher prices in 2023.
  • Lyn Alden provides important insight into the fundamental terrain on which AbbVie Inc. currently sits.
  • Although we see potential for higher prices, risks have risen. What would negate the likelihood of this possible upside move?



by Levi at StockWaves; produced with Avi Gilburt.

With a seemingly “positive” reaction to muted earnings, AbbVie Inc. (NYSE:ABBV) has a setup that can take it to new highs from here. What is the current landscape from the




StockWaves / MotiveWave


StockWave / MotiveWave



Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in ABBV over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.

STOCK WAVES:  Where fundamental analysis meets technical analysis for highest-probability investment opportunities!

“Thus far, the best stock-picking service I’ve seen–and I’ve been doing this for 35+ years! (Gunfighter)

“Stock Waves has produced more gains in the past month(+) than many sites do in years or decades.” (Keto)

“The amount of trades I’ve been able to take resulting in 100%+ returns is nothing short of amazing. If you do not have Stockwaves, you are only doing yourself a disservice.” (dgriff617)

Click here for a FREE TRIAL.

Leave a Reply

Your email address will not be published. Required fields are marked *